|
|
|
Volumn 52, Issue 3, 2011, Pages 142-143
|
|
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: Relevance of the CIRI-IV surveillance system
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INFLUENZA VACCINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHILD;
COST CONTROL;
COST OF ILLNESS;
DISEASE SURVEILLANCE;
DRUG COST;
GENERAL PRACTITIONER;
HEALTH CARE COST;
HEALTH CARE SYSTEM;
HUMAN;
INFANT;
INFECTION PREVENTION;
INFLUENZA A (H1N1);
INFLUENZA VACCINATION;
ITALY;
MAJOR CLINICAL STUDY;
NEWBORN;
PANDEMIC INFLUENZA;
PEDIATRICIAN;
PRESCHOOL CHILD;
SCHOOL CHILD;
SEASONAL INFLUENZA;
ADOLESCENT;
ADULT;
AGED;
CHILD;
CHILD, PRESCHOOL;
HUMANS;
INFANT;
INFANT, NEWBORN;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
ITALY;
MASS VACCINATION;
MIDDLE AGED;
PANDEMICS;
POPULATION SURVEILLANCE;
YOUNG ADULT;
|
|
EID: 80052946910
PISSN: 11212233
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (6)
|
